Back

Epidemiology and clinical trial data of lipoprotein(a).

26 August 2018 (13:17 - 13:34)
Organised by:
Congress Presentation Part of: Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

3 More presentations in this session

Presentation thumbnail
Basic science and mechanism of action of lipoprotein(a).
Professor S. Tsimikas (La Jolla, US)
Presentation thumbnail
Current and future treatment strategies to lower lipoprotein(a) .
Professor S. Nissen (Cleveland, US)
Presentation thumbnail
Panel discussion and Q&A.

Access the full session

Session thumbnail
Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options

The Event

Event poster

ESC Congress 2018

26 August 2018 13:17 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
28 August 2020
thumbnail
Congress Session
What you need to know about your patient’s lipid profile
26 August 2022
thumbnail
Congress Presentation
Lipid profile risk in menopausal women with no significant increase in lipoprotein(a)
31 August 2025
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources